{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-102213","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.217950+00:00","generated_at":"2026-06-17T01:49:29.237851+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MEI Pharma implements 1-for-20 reverse stock split to meet Nasdaq bid price rule","bullets":["Board set ratio at 1-for-20; filed Certificate of Amendment with Delaware on April 14, 2023.","Outstanding shares reduced from ~133.3M to ~6.7M; no fractional shares issued, cash in lieu.","Stockholders approved reverse split on Jan 5, 2023; trading starts post-split April 17 under MEIP.","New CUSIP 55279B301; exercise prices of options/warrants proportionally adjusted.","Computershare acting as transfer agent; book-entry holders need no action."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-102213","json":"https://secwatch.observer/filing/0001193125-23-102213.json","markdown":"https://secwatch.observer/filing/0001193125-23-102213.md","text":"https://secwatch.observer/filing/0001193125-23-102213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000119312523102213/0001193125-23-102213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000119312523102213/d483010d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:49:29.237851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3df57e192e8433809e35d79354f02fa603773137","claim":"Lite Strategy, Inc.: Filed a Certificate of Amendment to implement a 1-for-20 reverse stock split of common stock, par value $0.00000002 per share (effective 2023-04-14).","evidence_excerpt":"On April 14, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, to implement the 1-for-20 reverse split of its common stock (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1262104/000119312523102213/0001193125-23-102213-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-04-14"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}